Carregant...
Biosimilar Roadblock Removals Seem Tailor-Made for Trump/Democrats Agreement: Development of New Biosimilar Drugs and Marketing of Few Approved Drugs Stymied
The United States is lagging behind Europe in biosimilar use, and missing out on a wider range of medication options and huge savings in drug expenditures. What’s causing the holdup?
Guardat en:
| Publicat a: | P T |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MediMedia USA, Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355054/ https://ncbi.nlm.nih.gov/pubmed/30766009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|